Allspring Global Investments’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-58
Closed -$1.55K 2407
2023
Q3
$1.55K Sell
58
-101,264
-100% -$3.46M ﹤0.01% 2725
2023
Q2
$3.75M Buy
101,322
+38,312
+61% +$1.34M 0.01% 1070
2023
Q1
$1.97M Buy
63,010
+61,402
+3,819% +$1.98M ﹤0.01% 1250
2022
Q4
$47.9K Sell
1,608
-1,831
-53% -$65.5K ﹤0.01% 2342
2022
Q3
$131K Sell
3,439
-198
-5% -$9.93K ﹤0.01% 1972
2022
Q2
$198K Sell
3,637
-10,024
-73% -$551K ﹤0.01% 1819
2022
Q1
$852K Buy
13,661
+167
+1% +$11K ﹤0.01% 1981
2021
Q4
$1.36M Buy
+13,494
New +$1.19M ﹤0.01% 1756

Other funds holding FLGT

Allspring Global Investments's FLGT Position: Q4 2023 in Review

Allspring Global Investments sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 58 shares — an estimated $1.55K sold.

Allspring Global Investments first reported a position in FLGT in Q4 2021 and held it in 8 quarters. The position peaked at $3.75M in Q2 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Allspring Global Investments reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 58 Fulgent Genetics shares in Q4 2023, an estimated $1.55K.
  • Allspring Global Investments first reported a position in Fulgent Genetics in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Fulgent Genetics position peaked at $3.75M in Q2 2023.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.